Previous studies have reported implications of MDM2 and COP1 that targeted STAT3 for degradation in tumorigenesis [72,73], and involvement of MDM2 in RACK1-abrogated HDAC1 degradation during the pathogenesis of fulminant hepatitis [65]. The gene discussed is COP1; the disease is Fulminant hepatitis.